NextCure's macrophage-based alternative to T cell checkpoint inhibitors

Submitted by admin on March 4, 2019 - 11:53pm

Source:

BioCentury

News Tags:

NextCure

T cell checkpoint inhibitors

macrophages

Headline:

NextCure's macrophage-based alternative to T cell checkpoint inhibitors

snippet:

A study led by NextCure co-founder and PD-1 pioneer Lieping Chen has found that blocking SIGLEC15 could boost antitumor T cell responses in immunosuppressive tumor microenvironments.

Search form

You are here

NextCure's macrophage-based alternative to T cell checkpoint inhibitors

NextCure's macrophage-based alternative to T cell checkpoint inhibitors